A Study of Aripiprazole in Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Major Depressive Disorder
Interventions
DRUG

Aripiprazole+ ADT

Tablets, Oral, 2 - 20 mg variable dose once daily, 14 weeks

DRUG

Placebo+ ADT

Tablets, Oral, 2 - 20 mg variable dose once daily, 14 weeks

Trial Locations (34)

19063

Suburban Research Associates, Media

19104

University Of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

20037

George Washington University Medical Center, Washington D.C.

21208

Pharmasite Research, Inc., Baltimore

22903

University Of Virginia, Charlottesville

28211

Behavioral Health Center, Charlotte

29203

Usc School Of Medicine, Columbia

29407

Southeast Health Consultants, Charleston

30080

Carman Research, Smyrna

30912

Medical College Of Georgia, Augusta

33065

Cns Clinical Research Group, Coral Springs

35205

University Of Alabama At Birmingham, Birmingham

45408

Midwest Clinical Research Center, Dayton

48336

Summit Research Network, Farmington Hills

48507

Summit Research Network, Flint

53223

Northbrooke Research Center, Brown Deer

53562

Dean Foundation For Health Research & Education, Middleton

55101

Regions Hospital, Saint Paul

55454

University Of Minnesota, Minneapolis

60194

Comprehensive Neuroscience, Inc., Hoffman Estates

60640

Uptown Research Institute, Llc, Chicago

62025

Cunningham Clinical Research, Llc, Edwardsville

62711

Vine Street Clinical Research Center, Springfield

67211

Clinical Research Institute, Witchita

70115

Lsu Health Sciences Center, New Orleans

73104

Phebe Tucker, Md, Oklahoma City

78754

Community Clinical Research, Inc., Austin

84107

Radiant Research, Slc, Salt Lake City

84132

University Of Utah School Of Medicine, Salt Lake City

89146

Radiant Research Las Vegas, Las Vegas

92123

Sharp Mesa Vista Hospital, San Diego

97210

Summit Research Network, Portland

98004

Northwest Clinical Research Center, Bellevue

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY